Fig. 1 · Structure
Documents & Downloads
Vaxfectin
Vaccine Adjuvant
Vaxfectin is a second-generation cationic lipid-based adjuvant designed to enhance the efficacy of both plasmid DNA (pDNA) and protein-based vaccines. It significantly boosts the immune response to pDNA-expressed pathogenic antigens in vivo by increasing IgG titers and promoting an IL-6-dependent enhancement of the humoral immune response, while maintaining the Th1 type immune response. Vaxfectin is suitable for research applications in vaccine formulation and development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 370108-99-9 |
| Applications | Vaccine Adjuvant |
| Formula | C81H163BrN3O10P |
| Molecular Weight | 1450.05 |
| SMILES | NCCOP(OC[C@H](OC(CC(C)CCCC(C)CCCC(C)CCCC(C)C)=O)COC(CC(C)CCCC(C)CCCC(C)CCCC(C)C)=O)(O)=O.CCCC/C=C\CCCCCCCCOCC(C[N+](C)(C)CCCN)OCCCCCCCC/C=C\CCCC.[Br-] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.